Sarah J. Gutman

Sarah J. Gutman

Auto-generated profile, based on publicly available information

Sarah J. Gutman

Alfred Health, Melbourne, Victoria, Australia

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in JACC
Verified
Journal Article
Closed access
SPSandeep Prabhu
Sandeep Prabhu
ATAndrew J. Taylor
Andrew J. Taylor
BCBen T. Costello
Ben T. Costello
DKDavid M. Kaye
David M. Kaye
AMAlex J.A. McLellan
Alex J.A. McLellan
PKPeter M. Kistler
Peter M. Kistler

1 January 2016 in International Journal of Cardiology
Verified
Journal Article
Closed access
HRHashrul N.Z. Rashid
Hashrul N.Z. Rashid
DWDennis T.L. Wong
Dennis T.L. Wong
HWHarendra Wijesekera
Harendra Wijesekera
SGSarah J. Gutman
Sarah J. Gutman
VSVimal B. Shanmugam
Vimal B. Shanmugam
PPPeter J. Psaltis
Peter J. Psaltis

10 August 2018 in European Heart Journal
Verified
Journal Article
Closed access
SGSarah J Gutman
Sarah J Gutman
BCBenedict T Costello
Benedict T Costello
SPStavroula Papapostolou
Stavroula Papapostolou
AVAleksandr Voskoboinik
Aleksandr Voskoboinik
LILeah Iles
Leah Iles
ATAndrew J Taylor
Andrew J Taylor
In patients with non-ischaemic cardiomyopathy (NICM), the mortality benefit of a primary prevention implantable cardioverter-defibrillator (ICD) has been challenged. Left ventricular (LV) scar identified by cardiac magnetic resonance (CMR) imaging is associated with a high risk of malignant arrhythmia in NICM. We aimed to determine the impact of LV scar on the mortality benefit from a primary prevention ICD in NICM. We recruited 452 consecutive heart failure patients [New York Heart Association (NYHA) Class II/III] with NICM and LV ejection fraction ≤35% from a state-wide CMR service. All patients fulfilled European Society of Cardiology guidelines for primary prevention ICD implantation; however, the decision to implant was at the treating physician's discretion. Baseline clinical and CMR data were recorded prospectively and heart failure mortality risk (MAGGIC score) was calculated. The primary study outcome measurement was all-cause mortality based on presence or absence of ICD, stratified by LV scar. Median follow-up was 37.9 months and there was no difference in MAGGIC score between those who did and did not receive a primary prevention ICD (19.30 ± 5.46 vs. 18.90 ± 5.67, P = 0.50). In patients without LV scar, ICD implantation was not associated with improved mortality [hazard ratio (HR) = 1.22, 95% confidence interval (CI): 0.53-2.78, P = 0.64]. In patients with LV scar, ICD implantation was independently associated with reduced mortality (HR = 0.45, 95% CI: 0.26-0.77, P = 0.003). In patients with NICM, primary prevention ICD implantation is only associated with reduced mortality in patients with LV scar. This may enable more effective selection of NICM patients for ICD implantation compared with current guidelines.

1 August 2018 in JACC: Clinical Electrophysiology
Verified
Journal Article
Closed access
SPSandeep Prabhu
Sandeep Prabhu
BCBen T. Costello
Ben T. Costello
ATAndrew J. Taylor
Andrew J. Taylor
SGSarah J. Gutman
Sarah J. Gutman
AVAleksandr Voskoboinik
Aleksandr Voskoboinik
PKPeter M. Kistler
Peter M. Kistler

1 June 2019 in JACC: Clinical Electrophysiology
Verified
Journal Article
Closed access
HSHariharan Sugumar
Hariharan Sugumar
SPSandeep Prabhu
Sandeep Prabhu
AVAleksandr Voskoboinik
Aleksandr Voskoboinik
SYShane Young
Shane Young
SGSarah J. Gutman
Sarah J. Gutman
PKPeter M. Kistler
Peter M. Kistler